4065
PPB Group Berhad
Sector: Consumer | Market: MAIN
Key Financials
Extracted from official Bursa Malaysia quarterly filings. Latest 4 quarters, side by side.
Q4 FY2025Q3 FY2025Q2 FY2025Q1 FY2025
Income Statement
| Metric | Q4 FY2025 RM '000 | Q3 FY2025 RM '000 | Q2 FY2025 RM '000 | Q1 FY2025 RM '000 |
|---|---|---|---|---|
| Revenue | 5,431.848 | 1,378.449 | 2,710.909 | 1,351.126 |
| Income Statement | - | - | 0 | - |
| Cost of sales | -4,657.708 | -1,181.944 | -2,345.268 | -1,179.303 |
| Gross profit | 774.14 | 196.505 | 365.641 | 171.823 |
| Other operating income | 126.297 | - | 65.472 | 44.889 |
| Other operating income/(loss) | - | 38.511 | - | - |
| Operating expenses | -3.691 | - | - | - |
| Distribution costs | - | -51.997 | -98.64 | -49.974 |
| Administrative expenses | - | -63.686 | -119.091 | -56.85 |
| Other expenses | - | -1.177 | -1.405 | -0.673 |
| Finance costs | -27.725 | -6.919 | -16.307 | -8.521 |
| Share of results of associates | - | -264.359 | 528.11 | 309.699 |
| Share of results of joint venture | - | -0.106 | -0.005 | -0.046 |
| Profit before impairment on investment in an associate and taxation | 1,598.088 | - | - | - |
| Impairment on investment in an associate | -4,173.013 | - | - | - |
| (Loss)/Profit before taxation | -2,574.925 | -153.228 | - | - |
| Profit before taxation | - | - | 723.775 | 410.347 |
| Tax expense | -103.926 | -30.332 | -41.757 | -17.251 |
| Profit for the period | - | - | - | 393.096 |
| (Loss)/Profit for the period | - | -183.56 | - | - |
| (Loss)/Profit for the period/year | -2,678.851 | - | - | - |
| Net profit | - | - | 682.018 | - |
| Profit attributable to Owners of the parent | - | - | - | 375.827 |
| Attributable to Owners of the parent (Net profit) | - | -199.552 | - | - |
| (Loss)/Profit attributable to owners of the parent | -2,732.419 | - | - | - |
| Basic earnings per share (sen) | - | - | 0.046 | 0.026 |
| Basic (loss)/earnings per share (sen) | -0.192 | -0.014 | - | - |
Balance Sheet
| Metric | Q4 FY2025 RM '000 | Q3 FY2025 RM '000 | Q2 FY2025 RM '000 | Q1 FY2025 RM '000 |
|---|---|---|---|---|
| ASSETS | 0 | 0 | 0 | 0 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Property, plant and equipment | 1,187.671 | 1,190.164 | 1,198.209 | 1,215.843 |
| Investment properties | 359.517 | 362.132 | 335.345 | 334.796 |
| Right-of-use assets | 356.602 | 375.026 | 391.675 | 411.724 |
| Bearer plants | 3.793 | 3.814 | 3.917 | 4.075 |
| Land held for property development | 137.918 | 136.487 | 136.487 | 136.484 |
| Goodwill | 70.232 | 70.232 | 70.232 | 70.232 |
| Other intangible assets | 16.618 | 16.073 | 16.782 | 17.528 |
| Investment in associates | 18,004.279 | 21,544.331 | 22,026.284 | 22,796.841 |
| Investment in joint venture | 0 | 3.276 | 3.319 | 3.441 |
| Other investments | 332.01 | 322.761 | 308.001 | 327.802 |
| Deferred tax assets | 22.142 | 27.986 | 33.55 | 42.564 |
| Total non-current assets | 20,490.782 | 24,052.282 | 24,523.801 | 25,361.33 |
| Current assets | 0 | 0 | 0 | 0 |
| Inventories | 768.393 | 817.74 | 797.901 | 836.094 |
| Biological assets | 18.809 | 19.638 | 20.336 | 19.985 |
| Property development costs | 6.577 | 3.97 | 3.28 | 3.259 |
| Trade receivables | 631.569 | 634.616 | 627.221 | 679.345 |
| Other receivables | 140.442 | 169.991 | 167.795 | 218.448 |
| Derivative financial assets | 12.037 | 4.13 | 7.881 | 17.09 |
| Current tax assets | 9.555 | 11.888 | 8.63 | 9.201 |
| Cash and bank balances | 2,039.26 | 1,905.493 | 2,060.177 | 1,761.092 |
| Total current assets | 3,626.642 | 3,567.466 | 3,693.221 | 3,544.514 |
| TOTAL ASSETS | 24,117.424 | 27,619.748 | 28,217.022 | 28,905.844 |
| EQUITY AND LIABILITIES | 0 | 0 | 0 | 0 |
| Equity | 0 | 0 | 0 | 0 |
| Share capital | 1,429.314 | 1,429.314 | 1,429.314 | 1,429.314 |
| Reserves | 20,688.388 | 24,177.72 | 24,577.663 | 25,353.657 |
| Equity attributable to owners of the parent | 22,117.702 | 25,607.034 | 26,006.977 | 26,782.971 |
| Non-controlling interests | 633.181 | 671.549 | 655.123 | 656.634 |
| Total equity | 22,750.883 | 26,278.583 | 26,662.1 | 27,439.605 |
| Non-current liabilities | 0 | 0 | 0 | 0 |
| Borrowings | 192.857 | 218.624 | 337.606 | 289.147 |
| Lease obligations | 52.034 | 53.405 | 52.717 | 53.104 |
| Deferred tax liabilities | 140.328 | 138.263 | 136.119 | 138.032 |
| Provision for restoration cost | 50.616 | 49.119 | 49.12 | 49.24 |
| Total non-current liabilities | 522.801 | 539.391 | 560.548 | 589.594 |
| Current liabilities | 0 | 0 | 0 | 0 |
| Trade payables | 260.304 | 185.622 | 272.493 | 244.32 |
| Other payables | 308.835 | 315.735 | 296.572 | 268.434 |
| Derivative financial liabilities | 11.783 | 8.149 | 19.214 | 10.729 |
| Current tax liabilities | 17.927 | 20.239 | 15.772 | 10.911 |
| Total current liabilities | 843.74 | 801.774 | 994.374 | 876.645 |
| Total liabilities | 1,366.541 | 1,341.165 | 1,554.922 | 1,466.239 |
| TOTAL EQUITY AND LIABILITIES | 24,117.424 | 27,619.748 | 28,217.022 | 28,905.844 |
Cash Flow Statement
| Metric | Q4 FY2025 RM '000 | Q3 FY2025 RM '000 | Q2 FY2025 RM '000 | Q1 FY2025 RM '000 |
|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | 0 | 0 | 0 | 0 |
| Profit before taxation | - | 570.547 | 723.775 | 410.347 |
| (Loss)/Profit before taxation | -2,574.925 | - | - | - |
| Adjustments: | 0 | 0 | 0 | 0 |
| Non-cash items | 3,141.564 | -136.004 | -433.001 | -279.808 |
| Non-operating items | -47.648 | -33.756 | -22.312 | -6.992 |
| Operating profit before working capital changes | 518.991 | 400.787 | 268.462 | 123.547 |
| Working capital changes:- | 0 | 0 | 0 | 0 |
| Net change in current assets | 262.442 | 235.671 | 206.628 | 148.611 |
| Net change in current liabilities | 52.173 | -21.17 | 66.97 | -3.581 |
| Cash generated from operations | 833.606 | 615.288 | 542.06 | 268.577 |
| Tax paid | -78.494 | -54.939 | -34.161 | -22.503 |
| Net cash generated from operating activities | 755.112 | 560.349 | 507.899 | 246.074 |
| CASH FLOWS FROM INVESTING ACTIVITIES | 0 | 0 | 0 | 0 |
| Addition of property, plant and equipment, investment properties, biological assets and other intangible assets | - | -125.346 | -94.684 | -68.483 |
| Addition of property, plant and equipment, investment properties, biological assets, other intangible assets and land held for property development | -160.731 | - | - | - |
| Proceeds from disposal of property, plant and equipment | 0.774 | 0.371 | 0.324 | 0.279 |
| Investments in associates | -0.055 | -0.055 | 0 | - |
| Addition of other investment | -8.786 | 0 | -5 | 0 |
| Acquisition of a subsidiary | -45.304 | -45.304 | - | - |
| Dividends received | 584.942 | 580.212 | 402.703 | 9.177 |
| Investment in fixed deposits | -922.719 | - | - | - |
| Income received from short-term fund placements | 27.148 | 27.174 | 25.533 | 11.943 |
| Proceeds from disposal of an associate | 0 | 0 | 0 | - |
| Interest received | 24.359 | 14.187 | 6.964 | 3.956 |
| Advances to associates | - | - | - | -0.416 |
| Net cash used in investing activities | - | - | - | -43.544 |
| Repayment from associates | 49.086 | 49.335 | 49.84 | - |
| CASH FLOWS FROM FINANCING ACTIVITIES | 0 | 0 | 0 | 0 |
| (Repayment)/Drawdown of bank borrowings | - | -158.854 | -28.243 | -80.858 |
| Distribution of profit from joint venture | - | 0 | 0 | - |
| Net cash generated from investing activities | - | 500.574 | 390.68 | - |
| Interest paid | -11.765 | -10.157 | -7.179 | -3.817 |
| Distribution of profit from joint venture and associate | 5.31 | - | - | - |
| Dividends paid to non-controlling interests of subsidiaries | -31.781 | 0 | 0 | 0 |
| Net cash (used in)/generated from investing activities | -445.976 | - | - | - |
| Payment of lease obligations | -57.025 | -43.725 | -31.02 | -16.383 |
| Net cash (used in)/generated from financing activities | - | - | - | -101.058 |
| Net increase in cash and cash equivalents | - | 250.695 | 405.357 | 101.472 |
| Dividends paid to shareholders of the Company | -597.492 | -597.492 | -426.78 | - |
| Repayment of bank borrowings | -181.988 | - | - | - |
| Cash and cash equivalents brought forward | 1,660.658 | 1,660.658 | 1,660.658 | 1,660.658 |
| Effect of exchange rate changes | 26.798 | -5.86 | -5.838 | -1.038 |
| Cash and cash equivalents carried forward | 1,116.541 | 1,905.493 | 2,060.177 | 1,761.092 |
| Net cash used in financing activities | -880.051 | -810.228 | -493.222 | - |
| Cash and cash equivalents represented by: | 0 | 0 | 0 | 0 |
| Cash and bank balances | 451.257 | 444.629 | 346.376 | 184.223 |
| Bank deposits | 1,588.003 | 1,460.853 | 296.769 | 193.308 |
| Net decrease in cash and cash equivalents | -570.915 | - | - | - |
| Short-term fund placements | 0 | 0.011 | 1,417.032 | 1,383.561 |
| Less: Fixed deposits with tenure more than 3 months | -922.719 | - | - | - |
Investor Solutions
What's slowing down your research?
We're building customized tools for investors. Tell us your biggest challenge and we'll let you know when we solve it.